Edit Symbol List
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Company Description (as filed with the SEC)
We are a specialty pharmaceutical company dedicated to the development and commercialization of cardiovascular therapies that will improve the quality of life and health of patients suffering from heart disease. We strive to find innovative, differentiated medicines that provide therapeutic and economic value to patients, physicians and healthcare systems. We currently have two marketed, in-hospital, cardiology products, BRINAVESSTM and AGGRASTAT®, which are commercially available in numerous markets outside of the United States. Three Year History Collaboration Agreements In April 2009, we entered into a collaboration and license agreement with Merck & Co., Inc. ("Merck") for the development and commercialization of vernakalant (the "Collaboration Agreement"). The Collaboration Agreement provided an affiliate of Merck with exclusive global rights to vernakalant (oral) and exclusive rights outside of North America to vernakalant (IV). ... More ...
Where does CRME fit in the risk graph?
|Annual EPS Est:||$-1.12|
|Quarterly EPS Est:||-0.25|